3 Aggressive lymphoma that has failed at least one prior regimen of multiagent chemotherapy and patient is either ineligible for autologous BMT or autologous BMT is not recommended including Hodgkin lymphoma high grade Follicular lymphoma Mantle cell lymphoma Diffuse large B-cell lymphoma Burkitt's lymphoma/leukemia Anaplastic large cell lymphoma Plasmablastic lymphoma Peripheral T-cell lymphoma 